Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 May 23;49(9):4026–4035. doi: 10.1167/iovs.08-1807

FIGURE 4.

FIGURE 4

Lysosomotropic agents negatively affect HSV-1 entry. Monolayers of HCjE cells were either mock treated (No Treatment) or treated with indicated concentrations of bafilomycin (a) or chloroquine (b) and exposed to HSV-1 (50 PFU/cell). HeLa cells were also subjected to the same treatments and served as the positive control. Viral entry was measured using a spectrophotometer 6 hours after infection. Data shown are the means of triplicate measures and are representative of three independent experiments. The control (No Treatment) represents entry into corresponding mock-treated cells.